TGFB1 and small cell lung carcinoma: Enrichment analysis further indicated that the improved prognosis observed in the TGFB-HIGH group might be attributed to the STING-mediated type I interferon secretion and resultant immune activation, in conjunction with a weakened capacity for DNA repair and enhanced apoptosis, all of which subsequently promoted the sensitivity of SCLC to platinum-based chemotherapy.